Jaguar Health Inc. (JAGX)

1.68
1.03 158.46
NASDAQ : Health Technology
Prev Close 0.65
Open 1.10
Day Low/High 0.92 / 2.50
52 Wk Low/High 0.50 / 7.50
Volume 47.47M
Avg Volume 175.20K
Exchange NASDAQ
Shares Outstanding 9.53M
Market Cap 7.96M
EPS -7.70
Div & Yield N.A. (N.A)

Latest News

Jaguar Health To Host Conference Call Monday, January 22nd At 4:15 P.m. Eastern Time To Provide Updates Regarding Jaguar And Napo Pharmaceuticals Commercial, Educational & Product Development Activities And 2017 Results

Jaguar Health To Host Conference Call Monday, January 22nd At 4:15 P.m. Eastern Time To Provide Updates Regarding Jaguar And Napo Pharmaceuticals Commercial, Educational & Product Development Activities And 2017 Results

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription...

Napo Pharmaceuticals Comments On The Passing Of HIV/AIDS Activist And Research Pioneer Dr. Mathilde Krim

Napo Pharmaceuticals Comments On The Passing Of HIV/AIDS Activist And Research Pioneer Dr. Mathilde Krim

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of...

Jaguar Health And Dubai-based Seed Mena Enter Collaboration Agreement For Equilevia, Jaguar's Personalized, Premium Product For Total Gut Health And Wellness In Horses

Jaguar Health And Dubai-based Seed Mena Enter Collaboration Agreement For Equilevia, Jaguar's Personalized, Premium Product For Total Gut Health And Wellness In Horses

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

New Survey Finds People Living With HIV With Diarrhea Often Suffer In Silence

New Survey Finds People Living With HIV With Diarrhea Often Suffer In Silence

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of...

Jaguar Health Announces Adjournment Of Special Meeting Of Stockholders Until Friday, December 15, 2017

Jaguar Health Announces Adjournment Of Special Meeting Of Stockholders Until Friday, December 15, 2017

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription...

Keep Your Pants On Campaign From Napo Pharmaceuticals Chosen As Best HIV-Related Awareness Campaign Of 2017 By Healthline

Keep Your Pants On Campaign From Napo Pharmaceuticals Chosen As Best HIV-Related Awareness Campaign Of 2017 By Healthline

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of...

Jaguar Health Enters Share Purchase Agreement For 2 Million Shares And Common Stock Purchase Agreement Relating To A 10 Million Share Equity Line Offering With L2 Capital, LLC

Jaguar Health Enters Share Purchase Agreement For 2 Million Shares And Common Stock Purchase Agreement Relating To A 10 Million Share Equity Line Offering With L2 Capital, LLC

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription...

Jaguar Health Files First Quarterly Earnings Report Since July 2017 Merger With Napo Pharmaceuticals

Jaguar Health Files First Quarterly Earnings Report Since July 2017 Merger With Napo Pharmaceuticals

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar or the Company), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription...

Jaguar Health Presenting Neonorm Calf At Western Organic Dairy Producers Alliance Conference

Jaguar Health Presenting Neonorm Calf At Western Organic Dairy Producers Alliance Conference

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals...

Dr. Roscoe M. Moore Jr., DVM, MPH, Ph.D., DSc Joins Napo Pharmaceuticals Scientific Advisory Board For HIV For Mytesi, Napo's FDA-Approved Human Prescription Drug

Dr. Roscoe M. Moore Jr., DVM, MPH, Ph.D., DSc Joins Napo Pharmaceuticals Scientific Advisory Board For HIV For Mytesi, Napo's FDA-Approved Human Prescription Drug

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals...

Year-to-Date Gross Sales For Mytesi, The FDA-Approved Human Prescription Drug Product Of Jaguar Health's Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8 Million

Year-to-Date Gross Sales For Mytesi, The FDA-Approved Human Prescription Drug Product Of Jaguar Health's Wholly-Owned Subsidiary, Napo Pharmaceuticals, Total $2.8 Million

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals...

Today's Jaguar Health Conference Call Moved To 5:45 P.m. Eastern Time

Today's Jaguar Health Conference Call Moved To 5:45 P.m. Eastern Time

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals...

Jaguar Health To Host Earnings Conference Call Tuesday, November 14th At 4:30 P.m. Eastern Time

Jaguar Health To Host Earnings Conference Call Tuesday, November 14th At 4:30 P.m. Eastern Time

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Jaguar Health Enters Non-Binding Agreement Of Terms To Issue A Secured Convertible Note To Iliad Research And Trading, L.P. (an Affiliate Of Chicago Venture Partners, L.P.), As Jaguar Expands Commercial Efforts For Mytesi

Jaguar Health Enters Non-Binding Agreement Of Terms To Issue A Secured Convertible Note To Iliad Research And Trading, L.P. (an Affiliate Of Chicago Venture Partners, L.P.), As Jaguar Expands Commercial Efforts For Mytesi

Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar"), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Jaguar Health Receives Approval From The American Association Of Veterinary State Boards RACE Committee For Continuing Education Program For Veterinarians And Veterinary Technicians On Diarrhea In Foals

Jaguar Health Receives Approval From The American Association Of Veterinary State Boards RACE Committee For Continuing Education Program For Veterinarians And Veterinary Technicians On Diarrhea In Foals

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Jaguar Health Subsidiary Napo Pharmaceuticals Launches New Website For Mytesi, Napo's FDA-Approved, First-in-Class Anti-Secretory Human Prescription Drug

Jaguar Health Subsidiary Napo Pharmaceuticals Launches New Website For Mytesi, Napo's FDA-Approved, First-in-Class Anti-Secretory Human Prescription Drug

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Jaguar Health Subsidiary Napo Pharmaceuticals Launches National "Keep Your Pants On… Unless You Don't Want To" Campaign To Highlight The Need To Recognize And Treat Diarrhea In People Living With HIV/AIDS

Jaguar Health Subsidiary Napo Pharmaceuticals Launches National "Keep Your Pants On… Unless You Don't Want To" Campaign To Highlight The Need To Recognize And Treat Diarrhea In People Living With HIV/AIDS

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Jaguar Health Subsidiary Napo Pharmaceuticals Establishes Scientific Advisory Boards For Planned Follow-on Indications For Mytesi, Napo's FDA-approved Human Prescription Drug

Jaguar Health Subsidiary Napo Pharmaceuticals Establishes Scientific Advisory Boards For Planned Follow-on Indications For Mytesi, Napo's FDA-approved Human Prescription Drug

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

Napo Pharmaceuticals Endorses Prevention Access Campaign's U=U Consensus Statement For People Living With HIV/AIDS (PLWHA)

Napo Pharmaceuticals Endorses Prevention Access Campaign's U=U Consensus Statement For People Living With HIV/AIDS (PLWHA)

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of...

Jaguar Health Prices $4.25 Million Public Offering Of Common Stock

Jaguar Health Prices $4.25 Million Public Offering Of Common Stock

Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human...

Jaguar Subsidiary Napo Pharmaceuticals Files CMC Supplement With FDA For Sample-Size Bottles Of Mytesi, Napo's FDA-Approved Human Drug, To Support Upcoming National Sample Campaign

Jaguar Subsidiary Napo Pharmaceuticals Files CMC Supplement With FDA For Sample-Size Bottles Of Mytesi, Napo's FDA-Approved Human Drug, To Support Upcoming National Sample Campaign

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably-derived gastrointestinal products for both human prescription use and...

Jaguar Subsidiary Napo Pharmaceuticals And Glenmark Pharmaceuticals Sign Agreement Returning Key Rights In 141 Countries To Napo, Solidifying Jaguar's Global Commercial Control Of Mytesi (Crofelemer), Jaguar's FDA-Approved Human Drug

Jaguar Subsidiary Napo Pharmaceuticals And Glenmark Pharmaceuticals Sign Agreement Returning Key Rights In 141 Countries To Napo, Solidifying Jaguar's Global Commercial Control Of Mytesi (Crofelemer), Jaguar's FDA-Approved Human Drug

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably-derived gastrointestinal products for both human prescription use and...

FDA Indicates That Jaguar's Canalevia Drug Product Candidate Qualifies As "Minor Use" For Exercise-Induced Diarrhea (EID) In Dogs, Rendering Canalevia Eligible For Conditional Approval For This Indication

FDA Indicates That Jaguar's Canalevia Drug Product Candidate Qualifies As "Minor Use" For Exercise-Induced Diarrhea (EID) In Dogs, Rendering Canalevia Eligible For Conditional Approval For This Indication

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably-derived gastrointestinal products for both human prescription use and...

Advocates Tez Anderson And Josh Robbins To Host Facebook Live Conversation On 9/18 At 12 P.m. PT About Aging In The HIV+ / AIDS Community. (Photo: Business Wire)

Advocates Tez Anderson And Josh Robbins To Host Facebook Live Conversation On 9/18 At 12 P.m. PT About Aging In The HIV+ / AIDS Community. (Photo: Business Wire)

(NASDAQ: JAGX) - Today marks National HIV/AIDS and Aging Awareness Day (NHAAD), observed annually to focus on the challenges facing the aging population with regards to HIV prevention, testing, care and treatment.

Jaguar Health Announces Proposed Public Offering Of Common Stock

Jaguar Health Announces Proposed Public Offering Of Common Stock

Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human...

Jaguar Health Subsidiary Napo Pharmaceuticals Expands Mytesi Salesforce With Hire Of Experienced HIV & GI Drug Sales Reps In Key U.S. Markets

Jaguar Health Subsidiary Napo Pharmaceuticals Expands Mytesi Salesforce With Hire Of Experienced HIV & GI Drug Sales Reps In Key U.S. Markets

Jaguar Health, Inc. (NASDAQ: JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...

New Survey Ranks Diarrhea As Number One Gastrointestinal Complaint Of HIV/AIDS Patients

New Survey Ranks Diarrhea As Number One Gastrointestinal Complaint Of HIV/AIDS Patients

Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of...

Jaguar Health Company Name Now Updated On Nasdaq.com Post-Merger

Jaguar Health Company Name Now Updated On Nasdaq.com Post-Merger

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), a natural-products pharmaceuticals company focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and...